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Effects of dietary fatty acids in an animal model of focal glomerulo-
sclerosis. The obese Zucker rat develops hyperlipidemia, proteinuria
and focal glomeruloscierosis without prior changes in renal hemody-
namics. To study the effects of oral fatty acid intake on the development
of renal injury in this model, rats were fed standard chow or chow
supplemented with either 14% fish oil or 14% beef tallow after unilateral
nephrectomy at the age of 10 weeks. At 32 weeks post-nephrectomy
animals were sacrificed and renal tissue saved to assess histology and
glomerular eicosanoid production. Fish-oil treated rats had lower mean
plasma cholesterol levels and developed less proteinuria than control or
tallow-fed animals although there was no difference in plasma creatinine
or blood pressure. Histological analysis showed significantly fewer
scierosed glomeruli in the fish oil group (4.0 0.8% vs. control 19.4
4.1%, P < 0.0005 and vs. beef tallow 10.8 1.9%, P < 0.005).
Glomeruli derived from rats on fish oil supplements produced smaller
amounts of prostaglandin (PG)E2 and of the stable metabolites of PGI2
(6-oxo-PGF1,j, PGF2 (PGF2,) and thromboxane (TX)A2 (TXB2) than
those from tallow-fed animals. This study demonstrates that oral fatty
acid intake may influence the development of glomerulosclerosis. The
apparent beneficial effects of fish oil have not been fully defined, but
may relate to favorable changes in plasma lipid concentration and renal
eicosanoid production.
After a critical reduction in renal mass, organ failure may
progress even after the original insult has ceased [1]. The
glomeruli of this end stage kidney show the histological changes
of glomerulosclerosis, a lesion also seen in a variety of animal
models of renal disease [211. The mechanisms underlying the
development of glomeruloscierosis are not fully understood.
Studies in rats subjected to 5/ nephrectomy led Brenner and
colleagues to propose that an increase in intraglomerular pres-
sures and flow rates in remnant nephrons contributed to pro-
gressive renal injury [31. Although much attention has focused
on the possible detrimental effects of hyperfiltration, other
factors including intraglomerular coagulation, altered renal ei-
cosanoid production and abnormalities of lipid metabolism may
also contribute to glomerular scarring [4—6].
The obese Zucker rat provides a model of spontaneous.
glomerulosclerosis. Rats inherit obesity as an autosomal reces-
Received for publication February 20, 1990
and in revised form October 11, 1990
Accepted for publication December 20, 1990
© 1991 by the International Society of Nephrology
sive trait and develop hyperlipidemia and mild glucose intoler-
ance [7, 8]. Unilateral nephrectomy exacerbates lipid abnormal-
ities and accelerates the onset of proteinuria [9]. Phenotypically
lean rats have normal plasma lipid levels and are spared renal
injury [8]. Micropuncture studies have shown that lean and
obese animals have comparable intraglomerular pressures, sug-
gesting that glomerulosclerosis is not the result of hyperfiltra-
tion [10]. Kasiske and coworkers have recently demonstrated
specific differences in renal cortical lipids between obese and
lean rats and have proposed that such alterations, which may
result form abnormalities of lipid metabolism, contribute to the
pathogenesis of renal injury. In particular, they found a nega-
tive correlation between renal levels of the w-3 fatty acid
eicosapentenoic acid (EPA) and the degree of glomerular dam-
age [9].
Fish oils are rich in EPA and have a variety of biological
effects that may be beneficial in chronic renal disease. When
given as dietary supplements, these fatty acids are incorporated
into cell membrane phospholipids at the expense of arachidonic
acid, providing an alternative substrate for cyclooxygenase and
lipoxygenase enzymes and resulting in the synthesis of a
different spectrum of eicosanoids [11]. Although these effects
are best studied in platelets, fish oil supplements are also known
to modify renal prostaglandin and thromboxane synthesis [12].
Additional effects of these fatty acids that may benefit patients
with chronic renal disease include correction of hyperlipidemia
and reductions in blood viscosity which may improve renal
blood flow [13, 14].
This study compares the effects of diets supplemented with
fish oil and beef tallow (rich in saturated fats) on lipid abnor-
malities, renal eicosanoid synthesis and glomerulosclerosis in
the uninephrectomized obese Zucker rat model.
Methods
Experimental design
Forty male obese Zucker rats (Harlan Olac, Bicester, UK)
were obtained at eight weeks of age and subjected to unilateral
nephrectomy at 10 weeks. The thirty-nine rats that survived
surgery were divided into three groups of equal mean weight.
One group was fed a control diet, the other two received fat
supplemented diets. The weekly food intake of the three groups
was matched. Blood and urine samples were collected at
930
Wheeler et a!: Dietary fatty acids in glomerulosclerosis 931








Myristic (C14:0) 0.8% 6.0% 4.8%
Palmitic (C16:0) 18.6% 17.2% 25.2%
Stearic (C20:0) 1.7% 6.3% 16.9%
Other 1.6% 1.1% 4.8%
Monounsaturated
Palmitoleic (C16:1) 1.8% 6.3% 1.9%
Oleic (C18:l) 24.0% 17.3% 32.5%
Other 1.4% 2.1% 1.9%
Polyunsaturated
Linoleic (Cl8:2) 39.6% 8.3% 8.7%
Arachidonic (C20:4) 1.0% 2.7% 0.9%
Eicosapentenoic (C20:5) 2.4% 17.2% 0.4%
Docosahexenoic (C22:6) 3.6% 12.4% 0.6%
Other 3.5% 3.1% 1.4%
Numbers represent percentages of the total fatty acid content of each
diet
monthly intervals and rats sacrificed 32 weeks post-nephrec-
tomy. Renal tissue was saved for histological assessment and
glomeruli from animals fed fat supplemented diets isolated for
measurement of eicosanoid production.
Surgety
Animals were anesthetized by intramuscular injection of
Hypnorm (Janssen Pharmaceutical Ltd, Oxford, UK) compris-
ing fentanyl citrate (0.1 mg/kg body wt) and fluanisone (3.3
mg/kg) combined with an intraperitoneal injection of diazepam
(5 mg/kg). The right renal artery, vein and ureter were tied and
the right kidney removed via a midline abdominal incision.
Before closure, 2 ml of normal saline were instilled into the
abdomen to replace perioperative fluid losses.
Diets
Rats in the control group were fed standard chow (Modified
Maintenance Diet, Special Diet Services, Witham, UK) before
and after surgery. In the other two groups this basic diet was
supplemented from the time of nephrectomy onwards with
either 14% fish oil (Maxepa, Duncan Flockhart and Co Ltd,
Greenford, UK) or 14% melted beef tallow (Special Diet
Services). Both supplemented diets were identical in terms of
fat and protein content and were isocaloric, differing only in
their fatty acid composition (Table 1).
Blood and urine collections and analysis
To obtain 24-hour urine samples, rats were placed in meta-
bolic cages with free access to water but without food. After
this prolonged fast, blood samples were collected from a tail
artery under light anesthesia (fentanyl citrate 0.07 mg/kg and
fluanisone 2.2 mg/kg without diazepam). Plasma creatinine,
cholesterol and triglyceride were measured using enzymatic
assays and urinary protein by the benzethonium chloride tur-
bidimetric method on an RA1000 autoanalyzer (Technicon
Instruments Co Ltd, Basingstoke, UK).
Blood pressure estimation
Blood pressure was measured in lightly anesthetised rats at
20 and 32 weeks using a photoelectric tail cuff system (Harvard
Apparatus Ltd, Edenbridge, UK).
Histology
At sacrifice the remaining left kidney was perfused with
ice-cold phosphate buffered saline (pH 7.4), removed and
weighed. One coronal slice was saved for histology. This was
fixed in buffered 10% formalin, embedded in paraffin and
stained with periodic acid-Schiff. All tissue was assessed in a
blinded manner. In each section, all glomeruli in a central
wedge of cortex (approximately 40) were examined and scored.
This method avoided the possibility of assessing different parts
of each specimen. Glomeruloscierosis (characterized by scar-
ring and collapse of a proportion of the glomerular tuft) was
assessed and the area of involvement expressed as a percentage
of the total capillary area studied. The proportion of tubules
showing atrophic changes were counted and expressed as a
percentage of the total number examined.
Isolation and incubation of glomeruli
Glomeruli were isolated immediately by differential sieving of
renal tissue not required for histology [15]. Cortical fragments
were dissected from underlying medulla, ground to a pulp and
pressed through a 100 m brass sieve. Material collected from
the underside was then washed successively through 180 .tm
and 63 m brass sieves to retain tubular fragments and glomer-
uli, respectively. The isolated glomeruli were incubated in
Krebs-Ringer bicarbonate medium (pH 7.2) at 37°C for four
hours. Medium was collected after centrifugation and frozen at
—70°C. Glomeruli recovered in the pellet were solubilized in 0.5
M NaOH and quantified by measuring the protein content of this
suspension using the method of Lowry [16]. Concentrations of
prostaglandins PGE2, and of the stable metabolites of PG!2
(6-oxo-PGF1), PGF2 (PGF2) and TXA2 (TXB2) in incubation
medium were measured by radioimmunoassay using methods
previously described [17]. Production is expressed as pg ei-
cosanoid per mg glomerular protein per minute.
Statistics
Results were expressed as mean SEM. Statistical analysis
was performed using an unpaired Student's t-test and a P value
of <0.05 considered significant.
Results
Survival
Two control rats and one rat fed tallow died during the course
of the study and were eliminated from the final analysis. These
deaths were related to anesthesia at the time of blood collec-
tion.
Body weight
There was no difference in the mean body weight of the three
groups at sacrifice (control 575.1 21.1 g, fish oil 614.4 15.4
g and tallow 618 8.4 g). However, kidneys recovered from
fish oil-fed rats were significantly heavier than those of the other
two groups (fish oil 2.95 0.10 g vs. control 1.98 0.09 g, P <
0.0001 and vs. tallow 2.47 0.14 g, P < 0.05).
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Blood pressure
Systolic blood pressures were comparable in the three groups
at both week 20 (control 104 2 mm Hg, fish oil 102 3 mm Hg
and tallow 101 3 mm Hg) and week 32 (102 4, 100 3 and
98 2 mm Hg, respectively).
Plasma lipids
Fasting plasma triglyceride concentrations were lower in
both grOups of rats fed fat supplemented diets, particularly
those consuming fish oil, than in control rats at equivalent time
points (Fig. 1A). Differences between mean values of control
and fish oil groups reached statistical significance at week 4 and
from week 20 onwards, and between control and tallow grOups
at weeks 20 and 28 only. Triglyceride levels in tallow-fed rats
rose dramatically above control values between week 28 and
week 32. Final values in all groups at sacrifice were control 5.96
0.99 mmollliter, tallow 7.14 1.63 mmol/liter and fish oil 2.47
0.20 mmollliter (control vs. fish oil, P <0.001, and fish oil vs.
tallow P < 0.01). Fasting plasma cholesterol concentrations
were significantly lower in fish oil-fed rats than in both the other
two groups throughout the study period (Fig. 1 B). Mean values
in tallow-fed animals, although significantly higher than control
at weeks 12 and 16, fell to below control values at weeks 28 and
32. Final results in all groups were control 9.41 0.86 mmol/
liter, fish oil 3.40 0.44 mmol/liter and tallow 6.88 0.68
mmollliter (control vs. fish oil P < 0.0001, control vs. tallow P
<0.05 and fish oil vs. tallow P < 0.0005).
Proteinuria
Significant proteinuria (> 30 mg/day) developed between the
8th and 12th post-operative week (18 to 22 weeks of age) in
control and tallow-fed rats compared with the 20th and 24th
post-operative week (30 to 34 weeks of age) in the fish oil-fed
group (Fig. 2). Mean urinary protein excretion was significantly
lower in fish oil-fed rats compared with control and tallow-fed
from week 16 onwards, being less than half the mean value of
the other two groups at week 32 (fish oil 51,4 13.7 mg124 hr
vs. control 124.2 16.9 mg/24 hr, P < 0.005 and fish oil vs.
tallow 116.6 19.2 mg/24 hr, P < 0.01).
Plasma creatinine
Plasma creatinine concentration rose slightly in all three
groups but there was no significant difference between mean
values at any point in the study (Fig. 3). There was also a small
rise in creatinine clearance but again there was no difference
between the three groups at any stage.
Glomerular eicosanoid production
Glomeruli harvested from fish oil-fed rats produced signifi-
cantly smaller amounts of diene series eicosanoid (Fig. 4).
There was a marked difference in the production of vasocon-
strictor metabolites TXB2 (fish oil group 7.3 0.6 pg/mg/mm
vs. tallow group 25.7 6.0 pg/mg/mm, P < 0.005) and PGF2
(10.9 0.9 vs. 31.2 5.2, P < 0.001). Synthesis of the
vasodilatory prostaglandin PGE2 and of the PG!2 metabolite
6-oxo-PGF1c. was also reduced (PGE2 15,3 1.3 vs. 37.4 5.0,
P < 0.001 and 6-oxo-PGF1 68.1 6.5 vs. 171.8 24.3, P <
0.001). The overall ratio of vasodilator to vasoconstrictor
eicosanoid products was, however, unchanged.
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Fig. 1. Effect of dietary fatty acid intake on plasma lipids in uninephrec-
tomized obese Zucker rats. Mean (± SEM) total plasma (A) triglyceride
and (B) cholesterol concentrations of rats fed control (•, N = 11), fish
oil (0, N = 13) and beef tallow (0, N = 12) diets are plotted against
week post-nephrectomy (performed at 10 weeks of age). (*) significant











































Fig. 2. Effect of dietary fatty acid intake on proteinuria in uninephrec-
tomized obese Zucker rats. Mean (± SEM) 24-hour urinary protein
excretion of rats fed control (•, N 11), fish oil(O, N = 13) and beef
tallow (E, N = 12) diets is plotted against week post-nephrectorny. (*)
significant vs. control; (t) significant vs. tallow.
Histology
Glomeruli derived from rats in all three groups showed
characteristic changes of focal glomeruloscierosis and mesan-
gial matrix increase with collapse of portions of the glomerular
tuft and secondary tubular atrophy (Fig. 5). However, the
extent of glomerular damage was significantly less in the fish oil
compared with the other two groups (percentage sclerosis fish
oil 4.0 0.8% vs. control 19.4 4.1%, P < 0.0005 and fish oil
vs. tallow 10.8 1.9%, P < 0.005; Table 2). There was a
corresponding difference in the extent of tubular atrophy (fish
oil 5.9 1.1% vs. control 16.9 4.2%, P < 0.05, and fish oil vs.
tallow 18.6 4.4%, P < 0.05). Scarring was less extensive, but
tubular atrophy more marked in tallow-fed compared to control
rats, although these differences did not reach statistical signif-
icance.
Discussion
Histological similarities between glomerulosclerosis and ath-
erosclerosis are striking and have led to speculation that both
these lesions share a common pathogenesis [18]. Factors
thought to contribute to atherogenesis including endothelial
injury, lipid deposition, macrophage infiltration, cellular prolif-
eration and connective tissue deposition may therefore be
important in glomerular scarring [2]. This analogy is strength-
ened by the close relationship between vascular smooth muscle
I I I I I I I
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Fig. 3. Effect of dietary fatty acid intake on plasma creatinine in
uninephrectomized obese Zucker rats. Mean (± SEM) plasma creatinine
concentrations of rats fed control (•, N = 11), fish oil(O, N = 13) and
beef tallow (fl, N = 12) is plotted against post-operative week.
cells and mesangial cells and by the demonstration of extensive
lipid deposition in scarred glomeruli [19, 20].
In view of these similarities, treatment strategies used in the
prevention and treatment of atherosclerosis may also be appro-
priate in the management of patients with chronic progressive
glomerular disease. The association between hyperlipidemia
and cardiovascular disease is now well established and lipid
lowering agents have been shown to retard the development of
atherosclerosis in man [21, 22]. Recent animal studies have
suggested that abnormalities of lipid metabolism may also be
important in the pathogenesis of FGS and that lowering plasma
lipid levels may prevent progression of glomerular injury [23].
In addition, agents that inhibit thromboxane synthesis prevent
both coronary artery disease in man and glomerulosclerosis in
rats by mechanisms that may involve modification of platelet
function [5, 24].
Interest in the therapeutic properties of fish oils has arisen
from studies in Greenland Eskimos, who consume a traditional
diet of raw fish and seal and have a very low incidence of
cardiovascular and inflammatory disease [25]. Fish oil con-
sumption in humans results in lower plasma lipid levels [261,
prolonged bleeding times with reduced platelet aggregability
[27], changes in eicosanoid synthesis favoring vasodilatory
compounds [28] and reductions in neutrophil inflammatory
activity [29]. These observations have served as the rationale
for the use of fish oils in the prevention of atherosclerosis [30].
The effect of fish oil-enriched diets on renal injury has already
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Fig. 4. Effect of dieta,y fauy acid intake on glomerular
eicosanoid production in the uninephrectomized obese
Zucker rat. Glomeruli harvested from fish oil () and
beef tallow () fed rats at sacrifice were incubated in
Krebs-ringer bicarbonate buffer for 4 hours at 37°C.
Eicosanoid levels in the supernatants were measured by
specific radioimmunoassay and are expressed as pg
eicosanoid per mg cell protein per mm incubation time.
Mean and standard error bars are shown.
been investigated in a variety of models of glomerular disease.
In the lupus nephritis of NZBxNZW F1 and MRL-lpr mice,
fish oil feeding from birth prevents the development of protein-
uria and prolongs survival [12, 31]. Adriamyein treated rats
develop less glomerular injury on a 14% fish oil compared with
a beef tallow diet [32]. Salmon oil, also rich in EPA protects
against immune complex nephritis in mice given repeated
injections of apoferritin [33]. However conflicting results in
models of chronic progressive renal failure have generated
some controversy regarding the use of fish oils in the treatment
of renal disease [34, 35]. Scharschmidt et al found that rats
commenced on menhaden oil five weeks after /6 nephrectomy
suffered a more rapid decline in renal function and developed
more severe glomerulosclerosis when compared with partially
nephrectomized rats pair-fed beef tallow [341. The authors
suggested that this detrimental effect of fish oils was due to
inhibition of the vasodilatory prostaglandins E2 and '2which
maintain glomerular function in situations of renal compromise.
However, in a similar study, Barcelli et al found that salmon oil
ameliorated glomeruloscierosis without decreasing urinary
PGE2 excretion in ¾ nephrectomized rats when started two
weeks after less severe renal ablation [35]. In addition, diets
rich in the arachidonate precursor linoleic acid increase glomer-
ular POE2 production and preserve renal function following 3/4
nephrectoniy [36].
Studies in humans have shown that dietary fish oil supple-
mentation leads to alterations in renal hemodynamics. In 10
normal volunteers, increases in both glomerular filtration rate
and renal plasma flow were demonstrated after 10 weeks
supplementation [371. Other authors have examined the renal
response to a high protein meal in patients with chronic renal
failure and have demonstrated an enhanced increase in glomer-
ular filtration rate and decrease in renal vascular resistance after
four weeks of fish oil supplementation [38]. Conflicting results
have been reported in patients with IgA nephropathy. In a
controlled trial, fish oils preserved residual renal function in 20
patients with moderate insufficiency but made no difference to
a similar group in a separate study [39, 40]. In patients with
active lupus nephritis, o-3 fatty acid supplementation appar-
ently decreased renal histological activity as measured by a
decrease in urinary red cell casts [41], and rate of decline of
renal function was slowed in renal transplant patients with
chronic vascular rejection following introduction of fish oil [421.
The present study in the obese Zucker rat demonstrates that
fatty acid intake may influence the development of renal injury
and suggests that dietary fish oil supplementation may be
beneficial in reducing glomerular scarring. In terms of protein-
uria and histological injury, rats fed beef tallow did no worse or
better than those consuming standard chow. Although plasma
creatinine rose slightly in all three groups of rats, in a previous
short-term experiment it had not been possible to detect a
decline in renal plasma flow or glomerular filtration rate (mea-
sured by para-aminohippuric acid and inulin clearance, respec-
tively) despite similar rises in plasma creatinine [43]. To deter-
mine whether the apparent reduction in histological injury in
fish oil-fed animals is reflected in a slower rate of decline of
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Fig. 5. Typical renal lesions in obese Zucker rats. A. Normal glomerular architecture (x 400). B. Glomerulus showing matrix expansion and
collapse of capillary loops (x 400). C. Completely sclerosed glomerulus on left alongside a partially scierosed glomerulus showing hyalinosis
(arrowed) (x 200). D. Atrophic tubules (top left) contrasted with normal tubules (bottom right) (X 200).
Table 2. Effect of the dietary fatty acid intake on glomerular scarring
in the uninephrectomized obese Zucker rat





19.4 4.1 1 16.9 4.2 1
ia4.0 0.81 5.9 1.1 1a
10.8 1.81 18.6 4.41
Approximately 40 glomeruli from a central wedge of cortex in each
kidney were assessed. Figures represent the mean (± sEM) percentage
sclerosis and percentage tubular atrophy assessed as described in the
Methods section.
a p < 0.05
b P < 0.005
p < 0.0005
renal function, a longer study including such clearance mea-
surements would be required.
The precise mechanisms by which fish oil diets might modify
renal damage have not been defined. Previous studies using this
and other models have shown that lipid lowering agents ame-
liorate glomeruloscierosis so it seems likely that the lipid
lowering action of w-3 polyunsaturated fatty acids contributed
to their beneficial effect on the kidney [44j. Renal tissue lipid
composition may also be important in the development of renal
injury and is likely to be modified by changes in dietary fatty
acid intake. Tissue lipids were not measured directly in this
study, but differences in renal eicosanoid production were
demonstrated and are likely to reflect the availability of mem-
brane phospholipid fatty acid substrate [11]. In the Zucker
model, unlike the /6 nephrectomized rat, a decrease in glomer-
ular PGE2 production was not associated with a worse renal
prognosis. The fish oil diet might also be expected to favorably
modify the ratio of glomerular vasodilator to vasoconstrictor
eicosanoid production, but with respect to the diene series
measured in this study, no such changes were apparent. How-
ever, altered synthesis of EPA-derived products, which were
not directly assayed, cannot be excluded. Clearly, further
studies are required to define the role of altered renal prosta-
glandin production in the progression of glomerular disease.
Other actions of fish oil that may help to explain its protective
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effect remain purely speculative but include modification of
platelet and neutrophil function and changes in blood rheology
[14, 29, 30].
Manipulation of dietary fatty acid intake provides an attract-
ive approach to the prevention and treatment of chronic pro-
gressive renal disease in humans, but further study of the
mechanisms and safety of such intervention is required. Such
diets, which have been recommended in the prevention of
atherosclerosis, are particularly appropriate in such patients in
view of the high incidence of cardiovascular disease associated
with renal failure [45].
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